After over a century of failing to find a causal link between cannabis use and schizophrenia, proponents of Reefer Madness have had to couch their warnings.
The protective effect of cannabinoids for those living with Type 2 diabetes and obesity is particularly pronounced among people with schizophrenia. Why?
People have been studying the link between cannabis and schizophrenia for over a century. Research has not established strong evidence that cannabis causes schizophrenia, although there is an association. A new paper highlights some limitations of these studies.
The 27th meeting of the International Cannabinoid Research Society conference convened with over four hundred scientists presenting new research findings on a wide range of topics, including CBD and the endocannabinoid system. Read more about we learned about CBD and blood pressure, full-spectrum extracts, and medical use.
CBD can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Researchers at the University of Cologne in Germany studied 39 people with schizophrenia who were hospitalized for a psychotic episode.